Daniel Hendler

4.7k citations
21 papers · 3.9k · 2 hit papers · h-index 10

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • Cutaneous Melanoma Detection and Management
    • Cancer Treatment and Pharmacology
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 10%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Cutaneous Melanoma Detection and Management 2
    • Colorectal Cancer Treatments and Studies 2
    • Neutropenia and Cancer Infections 2
    • Breast Cancer Treatment Studies 5

Daniel Hendler

20 papers receiving 3.8k citations

Daniel Hendler's Hit Papers

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial 2021 · 300 citations
3000+8+17Years since publication1k2k3k

Peers

Daniel Hendler
Comparison fields: 5 of 93
  • Oncology 3.1k
  • Hepatology 90
  • Pharmacology 88
  • Geriatrics and Gerontology 25
  • Cancer Research 89
Replace Michel Homerin with:
Michel Homerin France
C. Wilson United Kingdom
Silvano Brienza France
Petr Karásek Czechia
Nicoletta Pirotta United States
G. Gruia France
Nathalie Le Bail France
AD Roth Spain
Corinne Couteau France
J-Y Douillard France
Daniel Hendler relative to Michel Homerin France Michel Homerin's profile →
Citations per field
00.5×1.5×2×2.4×
Michel Homerin · 1×
Citations per year

Countries citing papers authored by Daniel Hendler

Since Specialization
Citations

This map shows the geographic impact of Daniel Hendler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hendler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hendler more than expected).

Fields of papers citing papers by Daniel Hendler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Hendler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hendler. The network helps show where Daniel Hendler may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Hendler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Hendler Line = papers co-authored together Daniel Hendler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
Hit paper breakdown →
20003237
2
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
Hit paper breakdown →
2021300
3 2018180
4 202159
5 201631
6 201725
7 201119
8 202213
9 202313
10 202310
11 20148
12 20166
13 20165
14 20205
15 20205
16 20164
17 20194
18 20103
19 20212
20 20121

About Daniel Hendler

Daniel Hendler is a scholar working on Oncology, Cancer Research, Immunology, Dermatology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 3.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Cutaneous Melanoma Detection and Management (2 papers), Nonmelanoma Skin Cancer Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Neutropenia and Cancer Infections (2 papers), Chemotherapy-related skin toxicity (1 paper) and Smoking Behavior and Cessation (1 paper). The work is most often cited by research in Oncology (3.1k citations), Hepatology (90 citations), Pharmacology (88 citations), Geriatrics and Gerontology (25 citations) and Cancer Research (89 citations). Daniel Hendler has collaborated with scholars based in Israel, France and United States. Frequent co-authors include Nathalie Le Bail, Arié Figer, Andrès M.R. Cervantes, Corrado Boni, Gilles Freyer, Christophe Louvet, Filippo de Braud, H. Cortés-Funes, C. Wilson and Demetris Papamichael. Their work appears in journals such as The Lancet Oncology, Breast Cancer Research and Treatment, Journal of Clinical Oncology, BMC Cancer and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact